Abstract
This review gives a survey on the use and applications of technetium-94m (94mTc) as a non-conventional positron emission tomography (PET) radionuclide for molecular imaging. The first part of this review describes the production and processing of 94mTc. The second part covers basic concepts of technetium coordination chemistry with a special focus on the synthesis of 94mTc-labeled compounds for molecular imaging purposes. The review concludes with a summary and an outlook on the prospects of using 94mTc in the field of PET chemistry and molecular imaging.
Keywords: Technetium-94m, positron emission tomography, radiopharmaceuticals, molecular imaging, 94mTc Production, Thermochromatographic Separation, Solvent Extraction, PET Imaging, COORDINATION CHEMISTRY
Current Radiopharmaceuticals
Title: Radiotracers Based on Technetium-94m
Volume: 4 Issue: 2
Author(s): Katherine Gagnon, Steve McQuarrie, Doug Abrams, Alexander J. McEwan and Frank Wuest
Affiliation:
Keywords: Technetium-94m, positron emission tomography, radiopharmaceuticals, molecular imaging, 94mTc Production, Thermochromatographic Separation, Solvent Extraction, PET Imaging, COORDINATION CHEMISTRY
Abstract: This review gives a survey on the use and applications of technetium-94m (94mTc) as a non-conventional positron emission tomography (PET) radionuclide for molecular imaging. The first part of this review describes the production and processing of 94mTc. The second part covers basic concepts of technetium coordination chemistry with a special focus on the synthesis of 94mTc-labeled compounds for molecular imaging purposes. The review concludes with a summary and an outlook on the prospects of using 94mTc in the field of PET chemistry and molecular imaging.
Export Options
About this article
Cite this article as:
Gagnon Katherine, McQuarrie Steve, Abrams Doug, J. McEwan Alexander and Wuest Frank, Radiotracers Based on Technetium-94m, Current Radiopharmaceuticals 2011; 4 (2) . https://dx.doi.org/10.2174/1874471011104020090
DOI https://dx.doi.org/10.2174/1874471011104020090 |
Print ISSN 1874-4710 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4729 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pharmacokinetic Research Progress of Anti-tumor Drugs Targeting for Pulmonary Administration
Current Drug Metabolism Synthesis of Phosphorylated Derivatives of 2', 3'-O-Isopropylidene Adenosine and their In Ovo Antiviral Activity
Letters in Drug Design & Discovery Fullerenes for Cancer Diagnosis and Therapy: Preparation, Biological and Clinical Perspectives
Current Drug Metabolism Herpes Simplex Virus Type 1 Amplicons and their Hybrid Virus Partners, EBV, AAV, and Retrovirus
Current Gene Therapy Disposition of Flavonoids Impacts their Efficacy and Safety
Current Drug Metabolism Current Trends in Cancer Biomarker Discovery Using Urinary Metabolomics: Achievements and New Challenges
Current Medicinal Chemistry Pathogenic Genes Selection Model of Genetic Disease based on Network Motifs Slicing Feedback
Current Proteomics The miRNAs and Epithelial-Mesenchymal Transition in Cancers
Current Pharmaceutical Design Toll-Like Receptors: Cost or Benefit for Cancer?
Current Pharmaceutical Design Vascular Endothelial Growth Factor and Its Receptor as Drug Targets in Hematological Malignancies
Current Drug Targets Cancer Diagnosis and Disease Gene Identification <i>via</i> Statistical Machine Learning
Current Bioinformatics Molecular Remodeling of the Insulin Receptor Pathway by Thiazolidinediones in Type 2 Diabetes Mellitus: A Brief Review
Protein & Peptide Letters Optimization of the Enzymolysis Conditions for Scorpion Peptides and Evaluation of its Antitumor Activity
Current Signal Transduction Therapy MYC-Mediated Synthetic Lethality for Treating Tumors
Current Cancer Drug Targets Antiproliferative Effects of Nerium oleander Leaves and Their Cardiac Glycosides Odoroside A and Oleandrin on MCF-7 Cancer Cells
Current Traditional Medicine The c-Met Inhibitors: A New Class of Drugs in the Battle Against Advanced Nonsmall- Cell Lung Cancer
Current Pharmaceutical Design Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for Therapy
Current Pharmaceutical Design The Controlled Release of Drugs and Bioactive Compounds from Mesoporous Silica Nanoparticles
Current Drug Delivery Therapeutic Potential of Melatonin in the Regulation of MiR-148a-3p and Angiogenic Factors in Breast Cancer
MicroRNA Impact on DNA Methylation in Cancer Prevention and Therapy by Bioactive Dietary Components
Current Medicinal Chemistry